LMRI Stock — Lumexa Imaging Holdings, Inc. Common Stock

Lumexa Imaging Holdings, Inc. Common Stock (LMRI)

Updated October 16, 2026.

LMRI is a Stock. Total return is -41.7% over the past 0.8 years, 53.9 points behind SPY at 12.2%.

Lumexa Imaging Holdings operates diagnostic imaging centers across the United States, providing outpatient medical imaging services including MRI, CT, PET, X-ray, ultrasound, and mammography. The company does not currently have an established distribution schedule. This equity appeals primarily to investors seeking exposure to healthcare services and diagnostic imaging operations rather than current income.

LMRI performance versus SPY

Price and return data through 2026-10-16.

Total return is -41.7% over the past 0.8 years, 53.9 points behind SPY at 12.2%. Its deepest 1-year drawdown was 63.5%.

LMRI key facts

Asset type

Stock

Asset class

Equity

Inception date

12/10/2025

Distribution frequency

None

Last close

$10.78 (as of 2026-10-16)

Market cap

$1,035,688,241

Average volume

318502.0

Payout ratio

0.0%

Forward P/E

12.1106

EPS

$-0.37

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

LMRI risks and drawbacks

Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 63.5%.

Who may consider LMRI — and who may not

It is a weaker fit for investors who need monthly cash flow (LMRI does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on LMRI

• All tickers starting with L

Tagged: Healthcare.

Frequently asked questions